Concepedia

Author

Yuhong Mi

Beijing Anzhen Hospital

Also Known As

Mi Yuhong, Yu-Hong Mi, Yu-hong Mi, Yuhong Mi

39

Publications

559

Citations

9

H-Index

24

Concepts

All Affiliations

Beijing Anzhen HospitalCapital Medical UniversityUniversity of California SystemUniversity of PaviaUniversity of California San Diego
YM

About

Yuhong Mi is an author at Beijing Anzhen Hospital specializing in medicine, cardiovascular disease, and patient safety.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

64

2

Public Health

1

1

31

3

Cell Biology

1

1

16

4

Emergency Medicine

1

1

17

5

Pulmonary Disease

1

1

17

Yuhong Mi

×

7

Publications

405

Citations

7

H-Index

YearCitations

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini,

The Lancet Respiratory Medicine

2017

262

Extracorporeal Membrane Oxygenation for Critically Ill Patients With 2009 Influenza A (H1N1)‐Related Acute Respiratory Distress Syndrome: Preliminary Experience From a Single Center

Xiaotong Hou, Limin Guo, Qingyuan Zhan,

Artificial Organs

2012

34

Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction

Kun Zhang, Xinchao Zhang, Yuhong Mi,

Chinese Medical Journal

2013

33

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini,

The Lancet Respiratory Medicine

2024

31

Risk factors for noninvasive ventilation failure in patients with acute cardiogenic pulmonary edema: A prospective, observational cohort study

Zujin Luo, Fusheng Han, Hangyong He,

Journal of Critical Care

2017

17

BMP2/Smad signaling pathway is involved in the inhibition function of fibroblast growth factor 21 on vascular calcification

Xiaoxiao Liu, Fangying Cao, Shuang Liu,

Biochemical and Biophysical Research Communications

2018

16

Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism: one-year outcome.

Yuhong Mi, Ying Liang, Yanhui Lu,

PubMed

2013

12

Page 1